Thyrocare Technologies Ltd

NSE: THYROCARE · BSE: 539871 · Healthcare · 12 announcements

Share price: ₹566.85
Market cap: ₹9,022 Cr
Revenue (annual): ₹829.0 Cr
Net profit (annual): ₹163.0 Cr
P/E (TTM): 51.2×Sector 57.8×
Promoter holding: 60.92%+0.00% QoQ
FII holding: 5.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Share Pledge 1 Promoter Buying (Off-Market) 1 Merger & Restructuring 1 Financial Results 1 Employee Stock Options 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

27 Jul 2026 13:08 IST BSE

Earnings Call

Thyrocare Technologies Earnings Call Transcript: Key Takeaways

Thyrocare Q1 FY27: Consolidated revenue grew 24.3% YoY to INR 240 Cr, EBITDA margin expanded to 32.2%. Strategy shifts toward specialty diagnostics.

Call: Guides 18% growth

Open call summary → Read the filing ↗

23 Jul 2026 16:05 IST BSE

Earnings Call

Thyrocare Technologies Investor Presentation: Key Takeaways

Thyrocare delivered strong Q1 FY27 results with 24% YoY consolidated revenue growth and 34% YoY PAT growth, driven by pathology network expansion and high-value specialty test launches.

Call: Guides 20% growth

Open call summary → Read the filing ↗